These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37846574)

  • 21. Optic neuritis in Turkish children and adolescents: A multicenter retrospective study.
    Direk MÇ; Besen Ş; Öncel İ; Günbey C; Özdoğan O; Orgun LT; Sahin S; Cansu A; Yıldız N; Kanmaz S; Yılmaz S; Tekgül H; Türkdoğan D; Ünver O; Thomas GÖ; Başıbüyük S; Yılmaz D; Kurt AN; Gültutan P; Özsoy Ö; Yiş U; Kurul SH; Güngör S; Özgör B; Karadağ M; Dündar NO; Gençpınar P; Bildik O; Orak SA; Kabur ÇÇ; Kara B; Karaca Ö; Canpolat M; Gümüş H; Per H; Yılmaz Ü; Karaoğlu P; Ersoy Ö; Tosun A; Öztürk SB; Yüksel D; Atasoy E; Gücüyener K; Yıldırım M; Bektaş Ö; Çavuşoğlu D; Yarar Ç; Güngör O; Mert GG; Sarıgeçili E; Edizer S; Çetin İD; Aydın S; Diler B; Özdemir AA; Erol İ; Okuyaz Ç; Anlar B
    Mult Scler Relat Disord; 2024 Jan; 81():105149. PubMed ID: 38096730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in the treatment of neuromyelitis optica spectrum disorders related optic neuritis].
    Song HL; Xu QG; Wei SH
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):539-543. PubMed ID: 32842338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Kaneko K; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    J Neurol Sci; 2022 Jun; 437():120269. PubMed ID: 35483239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
    Matsumoto Y; Kaneko K; Takahashi T; Takai Y; Namatame C; Kuroda H; Misu T; Fujihara K; Aoki M
    Brain; 2023 Sep; 146(9):3938-3948. PubMed ID: 37061817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.
    Chen JJ; Flanagan EP; Pittock SJ; Stern NC; Tisavipat N; Bhatti MT; Chodnicki KD; Tajfirouz DA; Jamali S; Kunchok A; Eggenberger ER; Nome MAD; Sotirchos ES; Vasileiou ES; Henderson AD; Arnold AC; Bonelli L; Moss HE; Navarro SEV; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Wilf-Yarkoni A; Danesh-Meyer H; Ivanov S; Huda S; Forcadela M; Hodge D; Poullin P; Rode J; Papeix C; Saheb S; Boudot de la Motte M; Vignal C; Hacohen Y; Pique J; Maillart E; Deschamps R; Audoin B; Marignier R
    Am J Ophthalmol; 2023 Aug; 252():213-224. PubMed ID: 36822570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ; Bhatti MT
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica].
    Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):509-513. PubMed ID: 32842332
    [No Abstract]   [Full Text] [Related]  

  • 28. Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
    Feizi P; Sharma K; Pasham SR; Nirwan L; Joseph J; Jaiswal S; Sriwastava S
    J Neuroimmunol; 2022 Oct; 371():577939. PubMed ID: 35939945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes of first-ever episode of severe optic neuritis.
    Galetta K; Ryan S; Manzano G; Chibnik LB; Balaban D; Prasad S; Chwalisz BK; Salazar-Camelo A; Conway S; Levy M; Matiello M
    Mult Scler Relat Disord; 2022 Oct; 66():104020. PubMed ID: 35839615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
    Stiebel-Kalish H; Hellmann MA; Mimouni M; Paul F; Bialer O; Bach M; Lotan I
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e572. PubMed ID: 31355308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
    Dai Y; Ni S; Wu F; Guo S; Zhao X; Wang J
    J Clin Pharm Ther; 2022 Sep; 47(9):1379-1387. PubMed ID: 35488449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
    Jarius S; Aktas O; Ayzenberg I; Bellmann-Strobl J; Berthele A; Giglhuber K; Häußler V; Havla J; Hellwig K; Hümmert MW; Kleiter I; Klotz L; Krumbholz M; Kümpfel T; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Tumani H; Wildemann B; Trebst C;
    J Neurol; 2023 Jul; 270(7):3341-3368. PubMed ID: 37022481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
    Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent optic neuritis - Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease.
    Lotan I; Hellmann MA; Benninger F; Stiebel-Kalish H; Steiner I
    J Neuroimmunol; 2018 Nov; 324():115-118. PubMed ID: 30267996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD).
    Mewes D; Kuchling J; Schindler P; Khalil AAA; Jarius S; Paul F; Chien C
    Klin Monbl Augenheilkd; 2022 Nov; 239(11):1315-1324. PubMed ID: 36410333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
    Mult Scler Relat Disord; 2023 Apr; 72():104611. PubMed ID: 36907119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on Pediatric Optic Neuritis.
    Gise RA; Heidary G
    Curr Neurol Neurosci Rep; 2020 Mar; 20(3):4. PubMed ID: 32124097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment.
    Bennett JL; Costello F; Chen JJ; Petzold A; Biousse V; Newman NJ; Galetta SL
    Lancet Neurol; 2023 Jan; 22(1):89-100. PubMed ID: 36155661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis].
    Wei SH; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.